This page shows Nutanix Inc (NTNX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Nutanix Inc has an operating margin of 6.8%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is up from 0.4% the prior year.
Nutanix Inc's revenue surged 18.1% year-over-year to $2.5B, reflecting rapid business expansion. This strong growth earns a score of 64/100.
Nutanix Inc's current ratio of 1.89 indicates adequate short-term liquidity, earning a score of 34/100. The company can meet its near-term obligations, though with limited headroom.
Nutanix Inc converts 29.6% of revenue into free cash flow ($750.2M). This strong cash generation earns a score of 99/100.
Nutanix Inc scores 0.84, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($10.1B) relative to total liabilities ($4.0B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Nutanix Inc passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Nutanix Inc generates $4.36 in operating cash flow ($821.5M OCF vs $188.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Nutanix Inc generated $2.5B in revenue in fiscal year 2025. This represents an increase of 18.1% from the prior year.
Nutanix Inc's EBITDA was $245.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 203.7% from the prior year.
Nutanix Inc reported $188.4M in net income in fiscal year 2025. This represents an increase of 251.0% from the prior year.
Nutanix Inc earned $0.65 per diluted share (EPS) in fiscal year 2025. This represents an increase of 227.5% from the prior year.
Cash & Balance Sheet
Nutanix Inc generated $750.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 25.5% from the prior year.
Nutanix Inc held $780.4M in cash against $0 in long-term debt as of fiscal year 2025.
Nutanix Inc had 269M shares outstanding in fiscal year 2025. This represents an increase of 1.4% from the prior year.
Margins & Returns
Nutanix Inc's gross margin was 86.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.9 percentage points from the prior year.
Nutanix Inc's operating margin was 6.8% in fiscal year 2025, reflecting core business profitability. This is up 6.5 percentage points from the prior year.
Nutanix Inc's net profit margin was 7.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 13.2 percentage points from the prior year.
Capital Allocation
Nutanix Inc invested $736.8M in research and development in fiscal year 2025. This represents an increase of 15.3% from the prior year.
Nutanix Inc spent $307.9M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 134.8% from the prior year.
Nutanix Inc invested $71.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 5.3% from the prior year.
NTNX Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $354.2M-51.0% | $722.8M+7.8% | $670.6M+2.6% | $653.3M+2.2% | $639.0M-2.4% | $654.7M+10.8% | $591.0M+7.8% | $548.0M |
| Cost of Revenue | $8.8M-90.3% | $91.3M+4.3% | $87.5M+4.3% | $83.8M+1.0% | $83.0M-2.7% | $85.3M+3.2% | $82.7M+2.1% | $81.0M |
| Gross Profit | $345.4M-45.3% | $631.6M+8.3% | $583.1M+2.4% | $569.4M+2.4% | $556.0M-2.4% | $569.4M+12.0% | $508.3M+8.8% | $467.0M |
| R&D Expenses | $182.8M-9.6% | $202.3M+7.9% | $187.5M-3.2% | $193.7M+3.9% | $186.4M+2.0% | $182.8M+5.1% | $174.0M+3.9% | $167.4M |
| SG&A Expenses | $59.8M-11.5% | $67.6M+10.7% | $61.1M-3.5% | $63.3M+4.5% | $60.5M+1.2% | $59.8M+11.5% | $53.7M+2.4% | $52.4M |
| Operating Income | $65.4M-22.2% | $84.1M+70.5% | $49.3M+58.1% | $31.2M-35.8% | $48.6M-25.7% | $65.4M+140.1% | $27.3M+323.6% | -$12.2M |
| Interest Expense | $697K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $8.7M+256.9% | -$5.5M-258.6% | $3.5M-46.4% | $6.5M+425.3% | $1.2M-85.7% | $8.7M+25.5% | $6.9M-8.7% | $7.6M |
| Net Income | $56.4M-45.2% | $103.0M+65.9% | $62.1M+60.7% | $38.6M-39.0% | $63.4M+12.3% | $56.4M+88.6% | $29.9M+123.7% | -$126.1M |
| EPS (Diluted) | $0.19-47.2% | $0.36+71.4% | $0.21 | N/A | $0.22+15.8% | $0.19+90.0% | $0.10 | N/A |
NTNX Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.3B+0.2% | $3.3B-1.4% | $3.3B+1.2% | $3.3B+6.0% | $3.1B+3.6% | $3.0B+37.0% | $2.2B+1.7% | $2.1B |
| Current Assets | $2.6B+5.0% | $2.5B-6.5% | $2.6B+1.9% | $2.6B+7.4% | $2.4B+3.2% | $2.3B+53.3% | $1.5B+2.8% | $1.5B |
| Cash & Equivalents | $769.5M+27.5% | $603.4M-22.7% | $780.4M+1.4% | $769.5M-11.8% | $872.6M-18.6% | $1.1B+49.6% | $716.6M+9.4% | $655.3M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $338.0M+29.7% | $260.6M-22.4% | $335.9M-0.6% | $338.0M+25.1% | $270.2M-17.4% | $327.3M+64.8% | $198.6M-13.6% | $229.8M |
| Goodwill | $185.2M0.0% | $185.2M0.0% | $185.2M0.0% | $185.2M0.0% | $185.2M0.0% | $185.2M0.0% | $185.2M0.0% | $185.2M |
| Total Liabilities | $4.0B-3.2% | $4.1B+2.9% | $4.0B+0.4% | $4.0B+4.5% | $3.8B+0.3% | $3.8B+32.4% | $2.9B-0.2% | $2.9B |
| Current Liabilities | $1.4B-5.2% | $1.5B+6.5% | $1.4B-1.0% | $1.4B+10.3% | $1.3B-2.7% | $1.3B+7.9% | $1.2B-1.9% | $1.2B |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$694.5M+16.5% | -$831.3M-24.3% | -$668.6M+3.7% | -$694.5M+2.4% | -$711.4M+11.9% | -$807.7M-17.9% | -$685.3M+5.9% | -$728.1M |
| Retained Earnings | -$4.9B+1.8% | -$5.0B-2.3% | -$4.9B+0.5% | -$4.9B0.0% | -$4.9B+0.7% | -$4.9B-2.0% | -$4.8B+0.3% | -$4.8B |
NTNX Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $383.4M+94.3% | $197.3M+0.3% | $196.8M-10.3% | $219.5M+0.5% | $218.5M-1.4% | $221.7M+37.0% | $161.8M-33.9% | $244.7M |
| Capital Expenditures | $44.4M+649.6% | $5.9M-73.4% | $22.3M+89.9% | $11.8M-22.2% | $15.1M-56.4% | $34.6M+252.0% | $9.8M-51.9% | $20.4M |
| Free Cash Flow | $339.0M+77.1% | $191.4M+9.7% | $174.5M-16.0% | $207.8M+2.1% | $203.4M+8.7% | $187.1M+23.1% | $151.9M-32.3% | $224.3M |
| Investing Cash Flow | -$375.5M-5314.7% | $7.2M+109.7% | -$74.5M+67.0% | -$225.6M+35.7% | -$350.6M-1.0% | -$347.3M-1131.7% | -$28.2M-104.0% | $703.4M |
| Financing Cash Flow | $408.8M+207.2% | -$381.6M-242.6% | -$111.4M-14.8% | -$97.0M-43.3% | -$67.7M-114.1% | $481.1M+766.1% | -$72.2M+91.9% | -$892.6M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $220.1M-33.9% | $332.9M+562.8% | $50.2M+0.4% | $50.0M+32.5% | $37.8M-81.1% | $200.0M+895.0% | $20.1M-19.6% | $25.0M |
NTNX Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 97.5%+10.1pp | 87.4%+0.4pp | 87.0%-0.2pp | 87.2%+0.2pp | 87.0%+0.0pp | 87.0%+1.0pp | 86.0%+0.8pp | 85.2% |
| Operating Margin | 18.5%+6.8pp | 11.6%+4.3pp | 7.4%+2.6pp | 4.8%-2.8pp | 7.6%-2.4pp | 10.0%+5.4pp | 4.6%+6.8pp | -2.2% |
| Net Margin | 15.9%+1.7pp | 14.2%+5.0pp | 9.3%+3.3pp | 5.9%-4.0pp | 9.9%+1.3pp | 8.6%+3.6pp | 5.1%+28.1pp | -23.0% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 1.7%-1.4pp | 3.1%+1.3pp | 1.9%+0.7pp | 1.2%-0.9pp | 2.1%+0.2pp | 1.9%+0.5pp | 1.4%+7.2pp | -5.9% |
| Current Ratio | 1.83+0.2 | 1.65-0.2 | 1.89+0.1 | 1.83-0.0 | 1.88+0.1 | 1.77+0.5 | 1.25+0.1 | 1.19 |
| Debt-to-Equity | -5.73-0.8 | -4.94+1.0 | -5.97-0.2 | -5.73-0.4 | -5.35-0.7 | -4.70-0.5 | -4.18-0.2 | -3.94 |
| FCF Margin | 95.7%+69.2pp | 26.5%+0.5pp | 26.0%-5.8pp | 31.8%-0.0pp | 31.8%+3.3pp | 28.6%+2.9pp | 25.7%-15.2pp | 40.9% |
Note: Shareholder equity is negative (-$668.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What is Nutanix Inc's annual revenue?
Nutanix Inc (NTNX) reported $2.5B in total revenue for fiscal year 2025. This represents a 18.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nutanix Inc's revenue growing?
Nutanix Inc (NTNX) revenue grew by 18.1% year-over-year, from $2.1B to $2.5B in fiscal year 2025.
Is Nutanix Inc profitable?
Yes, Nutanix Inc (NTNX) reported a net income of $188.4M in fiscal year 2025, with a net profit margin of 7.4%.
What is Nutanix Inc's EBITDA?
Nutanix Inc (NTNX) had EBITDA of $245.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Nutanix Inc's gross margin?
Nutanix Inc (NTNX) had a gross margin of 86.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nutanix Inc's operating margin?
Nutanix Inc (NTNX) had an operating margin of 6.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Nutanix Inc's net profit margin?
Nutanix Inc (NTNX) had a net profit margin of 7.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Nutanix Inc's free cash flow?
Nutanix Inc (NTNX) generated $750.2M in free cash flow during fiscal year 2025. This represents a 25.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Nutanix Inc's operating cash flow?
Nutanix Inc (NTNX) generated $821.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Nutanix Inc's total assets?
Nutanix Inc (NTNX) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Nutanix Inc's capital expenditures?
Nutanix Inc (NTNX) invested $71.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Nutanix Inc spend on research and development?
Nutanix Inc (NTNX) invested $736.8M in research and development during fiscal year 2025.
What is Nutanix Inc's current ratio?
Nutanix Inc (NTNX) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.
What is Nutanix Inc's debt-to-equity ratio?
Nutanix Inc (NTNX) had a debt-to-equity ratio of -5.97 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nutanix Inc's return on assets (ROA)?
Nutanix Inc (NTNX) had a return on assets of 5.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is Nutanix Inc's debt-to-equity ratio negative or unusual?
Nutanix Inc (NTNX) has negative shareholder equity of -$668.6M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Nutanix Inc's Altman Z-Score?
Nutanix Inc (NTNX) has an Altman Z-Score of 0.84, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Nutanix Inc's Piotroski F-Score?
Nutanix Inc (NTNX) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nutanix Inc's earnings high quality?
Nutanix Inc (NTNX) has an earnings quality ratio of 4.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Nutanix Inc?
Nutanix Inc (NTNX) scores 58 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.